274 related articles for article (PubMed ID: 33774201)
1. Photo-responsive prodrug nanoparticles for efficient cytoplasmic delivery and synergistic photodynamic-chemotherapy of metastatic triple-negative breast cancer.
Jiao J; Lu H; Wang S
Acta Biomater; 2021 May; 126():421-432. PubMed ID: 33774201
[TBL] [Abstract][Full Text] [Related]
2. Dimeric Prodrug Self-Delivery Nanoparticles with Enhanced Drug Loading and Bioreduction Responsiveness for Targeted Cancer Therapy.
He X; Cai K; Zhang Y; Lu Y; Guo Q; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Li C; Sun T; Cheng J; Jiang C
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39455-39467. PubMed ID: 30362704
[TBL] [Abstract][Full Text] [Related]
3. Enhanced bioreduction-responsive diselenide-based dimeric prodrug nanoparticles for triple negative breast cancer therapy.
He X; Zhang J; Li C; Zhang Y; Lu Y; Zhang Y; Liu L; Ruan C; Chen Q; Chen X; Guo Q; Sun T; Cheng J; Jiang C
Theranostics; 2018; 8(18):4884-4897. PubMed ID: 30429875
[TBL] [Abstract][Full Text] [Related]
4. A self-assembly nano-prodrug for triple-negative breast cancer combined treatment by ferroptosis therapy and chemotherapy.
Chen Y; Yao Z; Liu P; Hu Q; Huang Y; Ping L; Zhang F; Tang H; Wan T; Ping Y; Li B
Acta Biomater; 2023 Mar; 159():275-288. PubMed ID: 36709836
[TBL] [Abstract][Full Text] [Related]
5. Sequentially-targeted biomimetic nano drug system for triple-negative breast cancer ablation and lung metastasis inhibition.
Fan J; Liu B; Long Y; Wang Z; Tong C; Wang W; You P; Liu X
Acta Biomater; 2020 Sep; 113():554-569. PubMed ID: 32569637
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of photodynamic therapy and chemotherapy: Activating the intrinsic/extrinsic apoptotic pathway of anoikis for triple-negative breast cancer treatment.
Zhang T; Wang X; Wang D; Lei M; Hu Y; Chen Z; Li Y; Luo Y; Zhang L; Zhu Y
Biomater Adv; 2024 Jun; 160():213859. PubMed ID: 38642515
[TBL] [Abstract][Full Text] [Related]
7. Theranostic nanoparticles for enzyme-activatable fluorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer.
Choi J; Kim H; Choi Y
Quant Imaging Med Surg; 2015 Oct; 5(5):656-64. PubMed ID: 26682135
[TBL] [Abstract][Full Text] [Related]
8. ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source.
Yue C; Yang Y; Zhang C; Alfranca G; Cheng S; Ma L; Liu Y; Zhi X; Ni J; Jiang W; Song J; de la Fuente JM; Cui D
Theranostics; 2016; 6(13):2352-2366. PubMed ID: 27877240
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Novel Nanoplatform for Effective Synergistic Chemo-Photodynamic Therapy of Breast Cancer by Enhancing DNA Damage and Disruptions of Its Reparation.
Huang Z; Xian T; Meng X; Hu H; Gao L; Huang J; Yang D; Ou K; Wang B; Zhang Y
Molecules; 2023 Oct; 28(19):. PubMed ID: 37836815
[TBL] [Abstract][Full Text] [Related]
10. Diselenium-linked dimeric prodrug nanomedicine breaking the intracellular redox balance for triple-negative breast cancer targeted therapy.
Chen M; Zhang M; Lu X; Li Y; Lu C
Eur J Pharm Biopharm; 2023 Dec; 193():16-27. PubMed ID: 37865134
[TBL] [Abstract][Full Text] [Related]
11. GSH-activable heterotrimeric nano-prodrug for precise synergistic therapy of TNBC.
Zhang X; Chen Y; Tang J; Chen C; Sun Y; Zhang H; Qiao M; Jin G; Liu X
Biomed Pharmacother; 2024 Apr; 173():116375. PubMed ID: 38460372
[TBL] [Abstract][Full Text] [Related]
12. Bioactivatable reactive oxygen species-sensitive nanoparticulate system for chemo-photodynamic therapy.
Kim Y; Uthaman S; Pillarisetti S; Noh K; Huh KM; Park IK
Acta Biomater; 2020 May; 108():273-284. PubMed ID: 32205212
[TBL] [Abstract][Full Text] [Related]
13. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
[TBL] [Abstract][Full Text] [Related]
14. Prostate-Specific Membrane Antigen and Esterase Dual Responsive Camptothecin-Oligopeptide Self-Assembled Nanoparticles for Efficient Anticancer Drug Delivery.
Xu B; Yan M; Zhou F; Cai D; Guo W; Jia X; Liu R; Ma T; Li T; Gao F; Wang P; Lei H
Int J Nanomedicine; 2021; 16():7959-7974. PubMed ID: 34887660
[TBL] [Abstract][Full Text] [Related]
15. A self-cascaded unimolecular prodrug for pH-responsive chemotherapy and tumor-detained photodynamic-immunotherapy of triple-negative breast cancer.
Yao D; Wang Y; Bian K; Zhang B; Wang D
Biomaterials; 2023 Jan; 292():121920. PubMed ID: 36442436
[TBL] [Abstract][Full Text] [Related]
16. High-Efficiency Synergistic Effect of Supramolecular Nanoparticles Based on Cyclodextrin Prodrug on Cancer Therapy.
Dai X; Zhang B; Zhou W; Liu Y
Biomacromolecules; 2020 Dec; 21(12):4998-5007. PubMed ID: 32946217
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte/platelet hybrid membrane-camouflaged dendritic large pore mesoporous silica nanoparticles co-loaded with photo/chemotherapeutic agents for triple negative breast cancer combination treatment.
Zhang T; Liu H; Li L; Guo Z; Song J; Yang X; Wan G; Li R; Wang Y
Bioact Mater; 2021 Nov; 6(11):3865-3878. PubMed ID: 33937590
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-Camptothecin Prodrug Nanoassemblies as a Versatile Nanoplatform for Biomodal Imaging-Guided Self-Active Targeted and Synergistic Chemotherapy.
Li Y; Lin J; Ma J; Song L; Lin H; Tang B; Chen D; Su G; Ye S; Zhu X; Luo F; Hou Z
ACS Appl Mater Interfaces; 2017 Oct; 9(40):34650-34665. PubMed ID: 28920426
[TBL] [Abstract][Full Text] [Related]
19. Aminoflavone-loaded EGFR-targeted unimolecular micelle nanoparticles exhibit anti-cancer effects in triple negative breast cancer.
Brinkman AM; Chen G; Wang Y; Hedman CJ; Sherer NM; Havighurst TC; Gong S; Xu W
Biomaterials; 2016 Sep; 101():20-31. PubMed ID: 27267625
[TBL] [Abstract][Full Text] [Related]
20. Polymeric Nanoparticles with ROS-Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer.
Hao Y; Chen Y; He X; Yu Y; Han R; Li Y; Yang C; Hu D; Qian Z
Adv Sci (Weinh); 2020 Oct; 7(20):2001853. PubMed ID: 33101874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
